{"address1": "Building 7", "address2": "Kiryat Atidim", "city": "Tel Aviv", "zip": "6158002", "country": "Israel", "phone": "972 77 331 0156", "website": "https://www.chemomab.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Adi Mor George Ph.D.", "age": 42, "title": "Co-Founder, Chief Scientific Officer, CEO & Executive Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sigal  Fattal CPA, M.B.A.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 322000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew B. Frankel M.B.A., M.D.", "age": 55, "title": "Chief Medical Officer & VP of Drug Development", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 850000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Barbara  Lindheim", "title": "Consulting Vice President of Investor & Public Relations, Strategic Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack  Lawler", "title": "Senior VP of Global Clinical Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.09, "open": 1.07, "dayLow": 1.01, "dayHigh": 1.07, "regularMarketPreviousClose": 1.09, "regularMarketOpen": 1.07, "regularMarketDayLow": 1.01, "regularMarketDayHigh": 1.07, "payoutRatio": 0.0, "beta": 0.493, "forwardPE": -26.0, "volume": 111757, "regularMarketVolume": 111757, "averageVolume": 370283, "averageVolume10days": 230480, "averageDailyVolume10Day": 230480, "bid": 1.02, "ask": 1.07, "bidSize": 1, "askSize": 1, "marketCap": 19610864, "fiftyTwoWeekLow": 0.579, "fiftyTwoWeekHigh": 2.55, "fiftyDayAverage": 1.66064, "twoHundredDayAverage": 1.539245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 378275520, "profitMargins": 0.0, "floatShares": 236378933, "sharesOutstanding": 18856600, "sharesShort": 269535, "sharesShortPriorMonth": 29261, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0143, "heldPercentInsiders": 0.15905, "heldPercentInstitutions": 0.25922, "shortRatio": 0.31, "shortPercentOfFloat": 0.014400001, "impliedSharesOutstanding": 11254500, "bookValue": 0.718, "priceToBook": 1.448468, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13945000, "trailingEps": -0.86, "forwardEps": -0.04, "lastSplitFactor": "1:16", "lastSplitDate": 1615939200, "enterpriseToEbitda": -25.782, "52WeekChange": 0.2887237, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.04, "targetHighPrice": 11.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 14266000, "totalCashPerShare": 0.038, "ebitda": -14672000, "totalDebt": 324000, "quickRatio": 4.961, "currentRatio": 4.984, "debtToEquity": 2.393, "returnOnAssets": -0.47101003, "returnOnEquity": -0.91341, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CMMB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Chemomab Therapeutics Ltd.", "longName": "Chemomab Therapeutics Ltd.", "regularMarketChange": -0.05000007, "regularMarketDayRange": "1.01 - 1.07", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 370283, "fiftyTwoWeekLowChange": 0.46099997, "fiftyTwoWeekLowChangePercent": 0.7962003, "fiftyTwoWeekRange": "0.579 - 2.55", "fiftyTwoWeekHighChange": -1.51, "fiftyTwoWeekHighChangePercent": -0.5921569, "fiftyTwoWeekChangePercent": 28.872372, "earningsTimestamp": 1741006800, "earningsTimestampStart": 1746615600, "earningsTimestampEnd": 1747047600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.86, "epsForward": -0.04, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -26.0, "fiftyDayAverageChange": -0.62064004, "fiftyDayAverageChangePercent": -0.37373546, "twoHundredDayAverageChange": -0.49924505, "twoHundredDayAverageChangePercent": -0.3243441, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1549981800000, "regularMarketChangePercent": -4.5871625, "regularMarketPrice": 1.04, "corporateActions": [], "regularMarketTime": 1743537602, "exchange": "NCM", "messageBoardId": "finmb_323539890", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Chemomab Therapeutics", "trailingPegRatio": null}